BlackRock reports 7.4% stake in Astera Labs
BlackRock, Inc. reports beneficial ownership of 12,667,232 shares of Astera Labs Inc. common stock, representing 7.4% of the outstanding class as of June 30, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
BlackRock, Inc. reports beneficial ownership of 12,667,232 shares of Astera Labs Inc. common stock, representing 7.4% of the outstanding class as of June 30, 2026. BlackRock has sole voting power over 11,998,990 shares and sole dispositive power over all 12,667,232 shares.
The position is held across certain reporting business units of BlackRock and its subsidiaries. Various underlying clients have rights to dividends and sale proceeds, but no single client has more than 5% of Astera Labs’ total outstanding common shares.
Key Figures
Key Terms
beneficially owned financial
sole voting power financial
sole dispositive power financial
percent of class financial
parent holding company financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What percentage of Astera Labs (ALAB) does BlackRock currently beneficially own?
Do any BlackRock clients individually hold more than 5% of Astera Labs (ALAB)?
Is BlackRock’s Astera Labs (ALAB) stake held by one entity or multiple units?
AI-generated analysis. How Rhea-AI works. Not financial advice.